Density Lowering Effect of "OFS Add on to TMX"(DELFINO Trial)
Status:
Recruiting
Trial end date:
2024-12-31
Target enrollment:
Participant gender:
Summary
DELFINO tial is designed to investigate the role of "OFS add on to TMX ", based on MMG
density as a surrogate marker in premenopausal women
- Premise - MMG density as a surrogate marker of hormone therapy
- Assumption - "Add on OFS to TMX" would have further decrease of density
- 3-arm(Observation arm + Randomised 2-arm), phase III, RCT with 1:1 allocation